APO Research, Inc.

APO RESEARCH · REPORT

Bushenyinao Capsule

Selected research

Market Outlook & Growth Opportunities

Global Bushenyinao Capsule Market Outlook and Growth Opportunities 2026

Market perspective

The global Bushenyinao Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bushenyinao Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bushenyinao Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bushenyinao Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bushenyinao Capsule market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bushenyinao Capsule market include Guangdong Luofushan National Pharmaceutical Co., Ltd., Guangdong Shaxi Pharmaceutical Co., Ltd., Guangxi Chanfang Pharmaceutical Co., Ltd., Heilongjiang Fuhe Pharmaceutical Group Co., Ltd., Jilin Aodong Yanbian Pharmaceutical Co., Ltd., Jilin Junhong Pharmaceutical Co., Ltd., Jilin Luwang Pharmaceutical Co., Ltd., Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. and Mudanjiang Lingtai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bushenyinao Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bushenyinao Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bushenyinao Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bushenyinao Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

Bushenyinao Capsule Segment by Company

Guangdong Luofushan National Pharmaceutical Co., Ltd.

Guangdong Shaxi Pharmaceutical Co., Ltd.

Guangxi Chanfang Pharmaceutical Co., Ltd.

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Jilin Junhong Pharmaceutical Co., Ltd.

Jilin Luwang Pharmaceutical Co., Ltd.

Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.

Mudanjiang Lingtai Pharmaceutical Co., Ltd.

Shaanxi Dongtai Pharmaceutical Co., Ltd.

Shantou Times Pharmaceutical Co., Ltd.

Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd.

Tonghua Dongbao Wuyao Co., Ltd.

Tonghua Heping Pharmaceutical Co., Ltd.

Tonghua Huaxia Pharmaceutical Co., Ltd.

Tonghua Huikang Biopharmaceutical Co., Ltd.

Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd.

Bushenyinao Capsule Segment by Type

30 Capsules Per Box

48 Capsules Per Box

Other

Bushenyinao Capsule Segment by Application

Hospital

Clinic

Other

Bushenyinao Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bushenyinao Capsule status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bushenyinao Capsule market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bushenyinao Capsule significant trends, drivers, influence factors in global and regions.

6. To analyze Bushenyinao Capsule competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bushenyinao Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bushenyinao Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bushenyinao Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bushenyinao Capsule market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bushenyinao Capsule industry.

Chapter 3: Detailed analysis of Bushenyinao Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bushenyinao Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bushenyinao Capsule in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bushenyinao Capsule Industry Trends Table 2. Bushenyinao Capsule Industry Drivers Table 3. Bushenyinao Capsule Industry Opportunities and Challenges Table 4. Bushenyinao Capsule Industry Restraints Table 5. Global Bushenyinao Capsule Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bushenyinao Capsule Revenue Share by Company (2021-2026) Table 7. Global Bushenyinao Capsule Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Bushenyinao Capsule Sales Volume Share by Company (2021-2026) Table 9. Global Bushenyinao Capsule Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bushenyinao Capsule Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bushenyinao Capsule Key Company Manufacturing Base & Headquarters Table 12. Global Bushenyinao Capsule Company, Product Type & Application Table 13. Global Bushenyinao Capsule Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bushenyinao Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 30 Capsules Per Box Table 18. Significant Companies of 48 Capsules Per Box Table 19. Significant Companies of Other Table 20. Global Bushenyinao Capsule Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Bushenyinao Capsule Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Bushenyinao Capsule Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Bushenyinao Capsule Sales Volume Share by Type (2021-2026) Table 24. Global Bushenyinao Capsule Sales Volume Share by Type (2027-2032) Table 25. Global Bushenyinao Capsule Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bushenyinao Capsule Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bushenyinao Capsule Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bushenyinao Capsule Sales Value Share by Type (2021-2026) Table 29. Global Bushenyinao Capsule Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Bushenyinao Capsule Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Bushenyinao Capsule Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Bushenyinao Capsule Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Bushenyinao Capsule Sales Volume Share by Application (2021-2026) Table 37. Global Bushenyinao Capsule Sales Volume Share by Application (2027-2032) Table 38. Global Bushenyinao Capsule Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bushenyinao Capsule Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bushenyinao Capsule Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bushenyinao Capsule Sales Value Share by Application (2021-2026) Table 42. Global Bushenyinao Capsule Sales Value Share by Application (2027-2032) Table 43. Global Bushenyinao Capsule Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Bushenyinao Capsule Sales by Region (2021-2026) & (K Units) Table 45. Global Bushenyinao Capsule Sales Market Share by Region (2021-2026) Table 46. Global Bushenyinao Capsule Sales by Region (2027-2032) & (K Units) Table 47. Global Bushenyinao Capsule Sales Market Share by Region (2027-2032) Table 48. Global Bushenyinao Capsule Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bushenyinao Capsule Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bushenyinao Capsule Sales Value Share by Region (2021-2026) Table 51. Global Bushenyinao Capsule Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bushenyinao Capsule Sales Value Share by Region (2027-2032) Table 53. Global Bushenyinao Capsule Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Bushenyinao Capsule Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Bushenyinao Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Bushenyinao Capsule Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bushenyinao Capsule Sales by Country (2021-2026) & (K Units) Table 58. Global Bushenyinao Capsule Sales Market Share by Country (2021-2026) Table 59. Global Bushenyinao Capsule Sales by Country (2027-2032) & (K Units) Table 60. Global Bushenyinao Capsule Sales Market Share by Country (2027-2032) Table 61. Global Bushenyinao Capsule Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bushenyinao Capsule Sales Value Market Share by Country (2021-2026) Table 63. Global Bushenyinao Capsule Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bushenyinao Capsule Sales Value Market Share by Country (2027-2032) Table 65. Guangdong Luofushan National Pharmaceutical Co., Ltd. Company Information Table 66. Guangdong Luofushan National Pharmaceutical Co., Ltd. Business Overview Table 67. Guangdong Luofushan National Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Guangdong Luofushan National Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 69. Guangdong Luofushan National Pharmaceutical Co., Ltd. Recent Development Table 70. Guangdong Shaxi Pharmaceutical Co., Ltd. Company Information Table 71. Guangdong Shaxi Pharmaceutical Co., Ltd. Business Overview Table 72. Guangdong Shaxi Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Guangdong Shaxi Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 74. Guangdong Shaxi Pharmaceutical Co., Ltd. Recent Development Table 75. Guangxi Chanfang Pharmaceutical Co., Ltd. Company Information Table 76. Guangxi Chanfang Pharmaceutical Co., Ltd. Business Overview Table 77. Guangxi Chanfang Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Guangxi Chanfang Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 79. Guangxi Chanfang Pharmaceutical Co., Ltd. Recent Development Table 80. Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Company Information Table 81. Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Business Overview Table 82. Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Bushenyinao Capsule Product Portfolio Table 84. Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Recent Development Table 85. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information Table 86. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview Table 87. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 89. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Development Table 90. Jilin Junhong Pharmaceutical Co., Ltd. Company Information Table 91. Jilin Junhong Pharmaceutical Co., Ltd. Business Overview Table 92. Jilin Junhong Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Jilin Junhong Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 94. Jilin Junhong Pharmaceutical Co., Ltd. Recent Development Table 95. Jilin Luwang Pharmaceutical Co., Ltd. Company Information Table 96. Jilin Luwang Pharmaceutical Co., Ltd. Business Overview Table 97. Jilin Luwang Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Jilin Luwang Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 99. Jilin Luwang Pharmaceutical Co., Ltd. Recent Development Table 100. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information Table 101. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview Table 102. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 104. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Development Table 105. Mudanjiang Lingtai Pharmaceutical Co., Ltd. Company Information Table 106. Mudanjiang Lingtai Pharmaceutical Co., Ltd. Business Overview Table 107. Mudanjiang Lingtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Mudanjiang Lingtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 109. Mudanjiang Lingtai Pharmaceutical Co., Ltd. Recent Development Table 110. Shaanxi Dongtai Pharmaceutical Co., Ltd. Company Information Table 111. Shaanxi Dongtai Pharmaceutical Co., Ltd. Business Overview Table 112. Shaanxi Dongtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Shaanxi Dongtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 114. Shaanxi Dongtai Pharmaceutical Co., Ltd. Recent Development Table 115. Shantou Times Pharmaceutical Co., Ltd. Company Information Table 116. Shantou Times Pharmaceutical Co., Ltd. Business Overview Table 117. Shantou Times Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Shantou Times Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 119. Shantou Times Pharmaceutical Co., Ltd. Recent Development Table 120. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Company Information Table 121. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Business Overview Table 122. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 124. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Recent Development Table 125. Tonghua Dongbao Wuyao Co., Ltd. Company Information Table 126. Tonghua Dongbao Wuyao Co., Ltd. Business Overview Table 127. Tonghua Dongbao Wuyao Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Tonghua Dongbao Wuyao Co., Ltd. Bushenyinao Capsule Product Portfolio Table 129. Tonghua Dongbao Wuyao Co., Ltd. Recent Development Table 130. Tonghua Heping Pharmaceutical Co., Ltd. Company Information Table 131. Tonghua Heping Pharmaceutical Co., Ltd. Business Overview Table 132. Tonghua Heping Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Tonghua Heping Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 134. Tonghua Heping Pharmaceutical Co., Ltd. Recent Development Table 135. Tonghua Huaxia Pharmaceutical Co., Ltd. Company Information Table 136. Tonghua Huaxia Pharmaceutical Co., Ltd. Business Overview Table 137. Tonghua Huaxia Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Tonghua Huaxia Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 139. Tonghua Huaxia Pharmaceutical Co., Ltd. Recent Development Table 140. Tonghua Huikang Biopharmaceutical Co., Ltd. Company Information Table 141. Tonghua Huikang Biopharmaceutical Co., Ltd. Business Overview Table 142. Tonghua Huikang Biopharmaceutical Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Tonghua Huikang Biopharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio Table 144. Tonghua Huikang Biopharmaceutical Co., Ltd. Recent Development Table 145. Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Company Information Table 146. Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Business Overview Table 147. Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Bushenyinao Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Bushenyinao Capsule Product Portfolio Table 149. Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Bushenyinao Capsule Distributors List Table 153. Bushenyinao Capsule Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Bushenyinao Capsule Product Image Figure 2. Global Bushenyinao Capsule Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bushenyinao Capsule Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bushenyinao Capsule Sales (2021-2032) & (K Units) Figure 5. Global Bushenyinao Capsule Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bushenyinao Capsule Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 30 Capsules Per Box Image Figure 10. 48 Capsules Per Box Image Figure 11. Other Image Figure 12. Global Bushenyinao Capsule Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Bushenyinao Capsule Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bushenyinao Capsule Sales Volume Share by Type (2021-2032) Figure 15. Global Bushenyinao Capsule Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bushenyinao Capsule Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bushenyinao Capsule Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Bushenyinao Capsule Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Bushenyinao Capsule Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bushenyinao Capsule Sales Volume Share by Application (2021-2032) Figure 24. Global Bushenyinao Capsule Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bushenyinao Capsule Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bushenyinao Capsule Sales Value Share by Application (2021-2032) Figure 27. Global Bushenyinao Capsule Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Bushenyinao Capsule Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bushenyinao Capsule Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bushenyinao Capsule Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bushenyinao Capsule Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bushenyinao Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bushenyinao Capsule Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bushenyinao Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bushenyinao Capsule Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bushenyinao Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bushenyinao Capsule Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bushenyinao Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bushenyinao Capsule Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bushenyinao Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bushenyinao Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bushenyinao Capsule Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bushenyinao Capsule Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 30 Capsules Per Box
  • 48 Capsules Per Box
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • Guangdong Shaxi Pharmaceutical Co., Ltd.
  • Guangxi Chanfang Pharmaceutical Co., Ltd.
  • Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
  • Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  • Jilin Junhong Pharmaceutical Co., Ltd.
  • Jilin Luwang Pharmaceutical Co., Ltd.
  • Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  • Mudanjiang Lingtai Pharmaceutical Co., Ltd.
  • Shaanxi Dongtai Pharmaceutical Co., Ltd.
  • Shantou Times Pharmaceutical Co., Ltd.
  • Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd.
  • Tonghua Dongbao Wuyao Co., Ltd.
  • Tonghua Heping Pharmaceutical Co., Ltd.
  • Tonghua Huaxia Pharmaceutical Co., Ltd.
  • Tonghua Huikang Biopharmaceutical Co., Ltd.
  • Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bushenyinao Capsule Sales Value (2021-2032)
  4. 1.2.2 Global Bushenyinao Capsule Sales Volume (2021-2032)
  5. 1.2.3 Global Bushenyinao Capsule Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bushenyinao Capsule Market Dynamics
  1. 2.1 Bushenyinao Capsule Industry Trends
  2. 2.2 Bushenyinao Capsule Industry Drivers
  3. 2.3 Bushenyinao Capsule Industry Opportunities and Challenges
  4. 2.4 Bushenyinao Capsule Industry Restraints
3 Bushenyinao Capsule Market by Company
  1. 3.1 Global Bushenyinao Capsule Company Revenue Ranking in 2025
  2. 3.2 Global Bushenyinao Capsule Revenue by Company (2021-2026)
  3. 3.3 Global Bushenyinao Capsule Sales Volume by Company (2021-2026)
  4. 3.4 Global Bushenyinao Capsule Average Price by Company (2021-2026)
  5. 3.5 Global Bushenyinao Capsule Company Ranking (2024-2026)
  6. 3.6 Global Bushenyinao Capsule Company Manufacturing Base and Headquarters
  7. 3.7 Global Bushenyinao Capsule Company Product Type and Application
  8. 3.8 Global Bushenyinao Capsule Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bushenyinao Capsule Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bushenyinao Capsule Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bushenyinao Capsule Market by Type
  1. 4.1 Bushenyinao Capsule Type Introduction
  2. 4.1.1 30 Capsules Per Box
  3. 4.1.2 48 Capsules Per Box
  4. 4.1.3 Other
  5. 4.2 Global Bushenyinao Capsule Sales Volume by Type
  6. 4.2.1 Global Bushenyinao Capsule Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bushenyinao Capsule Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bushenyinao Capsule Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bushenyinao Capsule Sales Value by Type
  10. 4.3.1 Global Bushenyinao Capsule Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bushenyinao Capsule Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bushenyinao Capsule Sales Value Share by Type (2021-2032)
5 Bushenyinao Capsule Market by Application
  1. 5.1 Bushenyinao Capsule Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Bushenyinao Capsule Sales Volume by Application
  6. 5.2.1 Global Bushenyinao Capsule Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bushenyinao Capsule Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bushenyinao Capsule Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bushenyinao Capsule Sales Value by Application
  10. 5.3.1 Global Bushenyinao Capsule Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bushenyinao Capsule Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bushenyinao Capsule Sales Value Share by Application (2021-2032)
6 Bushenyinao Capsule Regional Sales and Value Analysis
  1. 6.1 Global Bushenyinao Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bushenyinao Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global Bushenyinao Capsule Sales by Region: 2021-2026
  4. 6.2.2 Global Bushenyinao Capsule Sales by Region (2027-2032)
  5. 6.3 Global Bushenyinao Capsule Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bushenyinao Capsule Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bushenyinao Capsule Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bushenyinao Capsule Sales Value by Region (2027-2032)
  9. 6.5 Global Bushenyinao Capsule Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bushenyinao Capsule Sales Value (2021-2032)
  12. 6.6.2 North America Bushenyinao Capsule Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bushenyinao Capsule Sales Value (2021-2032)
  15. 6.7.2 Europe Bushenyinao Capsule Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bushenyinao Capsule Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bushenyinao Capsule Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bushenyinao Capsule Sales Value (2021-2032)
  21. 6.9.2 South America Bushenyinao Capsule Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bushenyinao Capsule Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bushenyinao Capsule Sales Value Share by Country, 2025 VS 2032
7 Bushenyinao Capsule Country-level Sales and Value Analysis
  1. 7.1 Global Bushenyinao Capsule Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bushenyinao Capsule Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bushenyinao Capsule Sales by Country (2021-2032)
  4. 7.3.1 Global Bushenyinao Capsule Sales by Country (2021-2026)
  5. 7.3.2 Global Bushenyinao Capsule Sales by Country (2027-2032)
  6. 7.4 Global Bushenyinao Capsule Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bushenyinao Capsule Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bushenyinao Capsule Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bushenyinao Capsule Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bushenyinao Capsule Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bushenyinao Capsule Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Guangdong Luofushan National Pharmaceutical Co., Ltd.
  2. 8.1.1 Guangdong Luofushan National Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Guangdong Luofushan National Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Guangdong Luofushan National Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Guangdong Luofushan National Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  6. 8.1.5 Guangdong Luofushan National Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Guangdong Shaxi Pharmaceutical Co., Ltd.
  8. 8.2.1 Guangdong Shaxi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Guangdong Shaxi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Guangdong Shaxi Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guangdong Shaxi Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  12. 8.2.5 Guangdong Shaxi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Guangxi Chanfang Pharmaceutical Co., Ltd.
  14. 8.3.1 Guangxi Chanfang Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Guangxi Chanfang Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Guangxi Chanfang Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guangxi Chanfang Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  18. 8.3.5 Guangxi Chanfang Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Bushenyinao Capsule Product Portfolio
  24. 8.4.5 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  26. 8.5.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  30. 8.5.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Jilin Junhong Pharmaceutical Co., Ltd.
  32. 8.6.1 Jilin Junhong Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jilin Junhong Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jilin Junhong Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jilin Junhong Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  36. 8.6.5 Jilin Junhong Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jilin Luwang Pharmaceutical Co., Ltd.
  38. 8.7.1 Jilin Luwang Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jilin Luwang Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Luwang Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  42. 8.7.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  44. 8.8.1 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  48. 8.8.5 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Mudanjiang Lingtai Pharmaceutical Co., Ltd.
  50. 8.9.1 Mudanjiang Lingtai Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Mudanjiang Lingtai Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Mudanjiang Lingtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mudanjiang Lingtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  54. 8.9.5 Mudanjiang Lingtai Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shaanxi Dongtai Pharmaceutical Co., Ltd.
  56. 8.10.1 Shaanxi Dongtai Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Shaanxi Dongtai Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Shaanxi Dongtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shaanxi Dongtai Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  60. 8.10.5 Shaanxi Dongtai Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Shantou Times Pharmaceutical Co., Ltd.
  62. 8.11.1 Shantou Times Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Shantou Times Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Shantou Times Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shantou Times Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  66. 8.11.5 Shantou Times Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd.
  68. 8.12.1 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  72. 8.12.5 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Tonghua Dongbao Wuyao Co., Ltd.
  74. 8.13.1 Tonghua Dongbao Wuyao Co., Ltd. Company Information
  75. 8.13.2 Tonghua Dongbao Wuyao Co., Ltd. Business Overview
  76. 8.13.3 Tonghua Dongbao Wuyao Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Tonghua Dongbao Wuyao Co., Ltd. Bushenyinao Capsule Product Portfolio
  78. 8.13.5 Tonghua Dongbao Wuyao Co., Ltd. Recent Developments
  79. 8.14 Tonghua Heping Pharmaceutical Co., Ltd.
  80. 8.14.1 Tonghua Heping Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Tonghua Heping Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Tonghua Heping Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Tonghua Heping Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  84. 8.14.5 Tonghua Heping Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Tonghua Huaxia Pharmaceutical Co., Ltd.
  86. 8.15.1 Tonghua Huaxia Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Tonghua Huaxia Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Tonghua Huaxia Pharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Tonghua Huaxia Pharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  90. 8.15.5 Tonghua Huaxia Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Tonghua Huikang Biopharmaceutical Co., Ltd.
  92. 8.16.1 Tonghua Huikang Biopharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Tonghua Huikang Biopharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Tonghua Huikang Biopharmaceutical Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Tonghua Huikang Biopharmaceutical Co., Ltd. Bushenyinao Capsule Product Portfolio
  96. 8.16.5 Tonghua Huikang Biopharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd.
  98. 8.17.1 Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Company Information
  99. 8.17.2 Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Business Overview
  100. 8.17.3 Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Bushenyinao Capsule Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Bushenyinao Capsule Product Portfolio
  102. 8.17.5 Zhejiang Youshengmet Traditional Chinese Medicine Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bushenyinao Capsule Value Chain Analysis
  2. 9.1.1 Bushenyinao Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bushenyinao Capsule Sales Mode & Process
  6. 9.2 Bushenyinao Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bushenyinao Capsule Distributors
  9. 9.2.3 Bushenyinao Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.